Overview

a Clinical Trial to Evaluate the Efficacy and Safety of Agnucaston Tablets in the Treatment of Premenstrual Syndrome (PMS)

Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and safety of Agnucaston tablets with placebo for the treatment of Premenstrual Syndrome (PMS) and assess if Agnucaston tablets are superior to placebo on efficacy or not.
Phase:
Phase 2
Details
Lead Sponsor:
Schwabe-Wenex International Ltd